BMS Archive

Plant · Scientific monograph

Asparagus racemosus

Shatavari

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Menopause research, Traditional Ayurvedic use

Research overview

Historical use

Shatavari root is described in Ayurveda as a traditional botanical used in women's health; traditional context is not proof of clinical benefit [1].

Modern research context

A placebo-controlled study assessed a proprietary Shatavari root extract at two follow-up points. It reported symptom and quality-of-life changes, but participant accounting, between-group analyses and adverse-event reporting were inconsistent. Findings do not establish efficacy or safety for other products [1].

Adverse effects

The report gives inconsistent adverse-event counts and descriptions, so its tolerability findings cannot be summarized reliably. The small 60-day trial does not establish uncommon or long-term harms [1].

Contraindications

Evidence is insufficient to establish safety in pregnancy, lactation or hormone-sensitive conditions. Do not interpret the trial as a recommendation or as evidence that it replaces clinical care [1].

Clinical and phytochemical data

Used part

Proprietary standardized root extract (Aspurūs; 5% total shatavarins), 250 mg capsule twice daily for 60 days in the trial [1].

Primary active compounds

    Mechanism of action

    The cited clinical trial does not establish a species-specific mechanism [1]. The cited human studies do not characterize an active compound or establish constituent-specific activity.

    Pharmacokinetics

    Absorption

    Human PK data for the trial formulation were not identified.

    Distribution

    Not characterized.

    Metabolism

    Not characterized.

    Excretion

    Not characterized.

    Safety and interactions

    Drug interactions

    No clinically characterized interaction study identified in the sources reviewed.

    Toxicity

    Long-term and rare toxicity are not established by a short trial [1].

    Special precautions

    Pregnancy

    Pregnancy safety is not established in the cited evidence.

    Lactation

    Lactation safety is not established by the cited trial.

    Hepatic impairment

    No data sufficient to characterize hepatic impairment.

    Renal impairment

    No data sufficient to characterize renal impairment.

    Sources and references

    1. [1] Gudise VS et al. Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial. Cureus. 2024;16(4):e57879. PMID: 38725785. DOI: 10.7759/cureus.57879.

    Additional source links

    Continue browsing